63
Views
9
CrossRef citations to date
0
Altmetric
Review

Cluster headache: focus on emerging therapies

&
Pages 895-907 | Published online: 10 Jan 2014

References

  • D'Alessandro R, Gamberini G, Benassi G, Morganti G, Cortelli P, Lugaresi E. Cluster headache in the Republic of San Marino. Cephalalgia 6,159–162 (1986).
  • Ekbom K, Ahlborg B, Schele R. Prevalence of migraine and cluster headache in Swedish men of 18. Headache 18,9–19 (1978).
  • Swanson JW, Yanagihara T, Stang PE etal Incidence of cluster headaches: a population-based study in Olmsted County, Minnesota. Neurology 44, 433–437 (1994).
  • Sjaastad 0, Bakketeig LS. Cluster headache prevalence. Vaga study of headache epidemiology. Cephalalgia 23, 528–533 (2003).
  • Torelli P, Beghi E, Manzoni GC. Cluster headache prevalence in the Italian general population. Cephalagia 23,598 (2003).
  • Manzoni GC. Gender ratio of cluster headache over the years: a possible role of changes in lifestyle. Cephalalgia 18, 138–142 (1998).
  • Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 58, 354–361 (2002).
  • Lance JVV, Goadsby PJ. Mechanisms and management of headache. Butterworth-Heinemann, London, UK (1998).
  • Headache Classification Committee of The International Headache Society. TheInternational Classification of Headache Disorders. Second Edition. Cephalalgia 24, 1–195 (2004).
  • Silberstein SD, Niknam R, Rozen TD, Young WB. Cluster headache with aura. Neurology54,219–221 (2000).
  • Siow HC, Young WB, Peres MF, Rozen TD, Silberstein SD. Hemiplegic cluster. Headache 42,136–139 (2002).
  • Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 120,193–209 (1997).
  • May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 352, 275–278 (1998).
  • •Positron emission tomography study showing activation of the posterior inferior hypothalamus in cluster headache (CH).
  • Sprenger T, Boecker H, Tolle TR, Bussone G, May A, Leone M. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology62,516–517 (2004).
  • May A, Ashburner J, Buchel C eta]. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nature Med. 5,836–838 (1999).
  • Manzoni GC, Micieli G, Granella F, Tassorelli C, Zanferrari C, Cavallini A. Cluster headache-course over ten years in 189 patients. Cephalalgia11,169–174 (1991).
  • Igarashi H, Sakai E Natural history of cluster headache. Cephalalgia 16,390–391 (1996).
  • The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl. Med. 325,322–326 (1991).
  • Ekbom K, Waldenlind E, Cole J, Pilgrim A, Kirkham A. Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia 12,254–256 (1992).
  • Ekbom K, Krabbe A, Micieli G et al Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Cephalalgia 15,230–236 (1995).
  • Gobel H, Lindner V, Heinze A, Ribbat M, Deuschl G. Acute therapy for cluster headache with sumatriptan: findings of a 1-year long-term study. Neurology51, 908–911 (1998).
  • Manzoni GC. Cluster headache and lifestyle: remarks on a population of 374 male patients. Cephalalgia 19,88–94 (1999).
  • Van Vliet JA, Bahra A, Martin V et al Intranasal sumatriptan in cluster headache: Randomized placebo-controlled double-blind study. Newology60,630–633 (2003).
  • Monstad I, Krabbe A, Micieli G etal Preemptive oral treatment with sumatriptan during a cluster period. Headache 35,607–613 (1995).
  • Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 54,1832–1839 (2000).
  • Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen vs. air inhalation. Arch. Neural. 42,362–363 (1985).
  • Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache 21, 1–4 (1981).
  • Igarashi H, Sakai F, Tazaki Y. The mechanism by which oxygen interrupts cluster headache. Cephalalgia11,238–239 (1991).
  • Porta M, Granella F, Coppola A, Longoni C, Manzoni GC. Treatment of cluster headache attacks with hyperbaric oxygen. Cephalagia 11 (Suppl. 11), 236–237 (1991).
  • Di Sabato F, Fusco BM, Pelaia P, Giacovazzo M. Hyperbaric oxygen therapy in cluster headache. Pain 52,243–245 (1993).
  • Nilsson Remahl Al, Ansjon R, Lind F, Waldenlind E. Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study. Cephalalgia 22,730–739 (2002).
  • Robbins L. Intranasal lidocaine for cluster headache. Headache 35,83–84 (1995).
  • Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 63,1637–1677 (2003).
  • •Reviews the primary headache syndromes recognized as trigeminal autonomic cephalgias. It contains a detailed literature survey on the reports of medical treatments for CH.
  • Friedman AP, Mikropoulos HE. Cluster headaches. Neurology8, 653–663 (1958).
  • Horton BT Histaminic cephalgia. Lancet 72,92-98 (1952).
  • Dodick DW, Rozen TD, Goadsby PJ, Silberstein SD. Cluster headache. Cephalalgla 20,787–803 (2000).
  • •Comprehensive review of the clinical phenotype, pathophysiology and treatments of CH.
  • Andersson PG, Jespersen LT Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. A double-blind trial versus placebo. Cephalalgla 6,51–54 (1986).
  • Goadsby PJ. The pharmacology of headache. Frog: Neumbial 62,509–525 (2000).
  • Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 117,427–434 (1994).
  • Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60,119–123 (1995).
  • Helyes Z, Pinter E, Nemeth J etal Anti- inflammatory effect of synthetic somatostatin analogs in the rat. BE j Pharmacol 134,1571–1579 (2001).
  • Fassler JE, O'Dorisio TM, Mekhjian HS, Gaginella TS. Octreotide inhibits increases in short-circuit current induced in rat colon by VIP, substance P, serotonin and aminophylline. Regul Pept. 29,189–197 (1990).
  • Sicuteri F, Geppetti P, Marabini S, Lembeck E Pain relief by somatostatin in attacks of cluster headache. Pain 18,359–365 (1984).
  • Geppetti P, Brocchi A, Caleri D, Marabini S, Raino L, Renzi D. Somatostatin for cluster headache attack. In: Updating- in Headache. Pfaffenrath V, Lundberg PO, Sjaastad 0 (Eds). Springer-Verlag, NY, USA, 302–305 (1985).
  • Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide is effective in the treatment of acute cluster headache: a double-blind placebo-controlled crossover study. Cephalagla 23, 580 (2003).
  • Rozen TD. Olanzapine as an abortive agent for cluster headache. Headache 41, 813–816 (2001).
  • Gabai IJ, Spierings EL. Prophylactic treatment of cluster headache with verapamil. Headache 29,167–168 (1989).
  • Bussone G, Leone M, Peccarisi C etal Double-blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache30, 411–417 (1990).
  • Leone M, D'Amico D, Frediani F etal Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology54,1382–1385 (2000).
  • Krabbe A, Steiner TJ. Prophylactic treatment of cluster headache. In: Cluster Headache Syndrome in General Practice: Basic Concepts. Sjaastad 0, Nappi G (Eds). Smith-Gordon, London, UK, 91–96 (2000).
  • Kudrow L. Lithium prophylaxis for chronic cluster headache. Headachel7, 15–18 (1977).
  • Ekbom K. Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 21,132–139 (1981).
  • Kudrow L. Cluster headache. In: Clinical Therapeutic, Conceptual and Research Aspects. Blau JN (Ed.). Chapman and Hall, London, UK (1987).
  • Curran DA, Hinterberger H, Lance JW. Methysergide. Res. Clin. Studies Headache 1,74–122 (1967).
  • Graham JR, Suby HI, LeCompte PR, Sadowsky NL. Fibrotic disorders associated with methysergide therapy for headache. N Engl. I Med. 274,360–368 (1966).
  • Raskin NH. Headache. Churchill Livingstone, NY, USA (1988).
  • Berde B, Schild HO. Ergot Alkaloids and Related Compounds. Springer-Verlag, Berlin, Germany (1978).
  • Garrison JC. Histamine, bradykinin, 5- hydroxytryptamine and their antagonists. In:The Pharmacological Basis of Therapeutics. Gilman AG, Rall TVV, Niles AS, Taylor P (Eds). Pergamon Press, NY, USA, 595 (1990).
  • Saxena PR, Den Boer MO. Pharmacology of antimigraine drugs. I Neural 238, S28—S35 (1991).
  • Blakeborough P, Fowler PA, Ashford EA. The use of sumatriptan in patients taking migraine prophylactic agents. Cephalalgla 13,163 (1993).
  • Liston H, Bennett L, Usher B Jr, Nappi J. The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman. Arch. Intern. Med. 159,511–513 (1999).
  • Symonds CR A particular variety of headache. Brain 79,217–232 (1956).
  • Mather PJ, Silberstein SD, Schulman EA, Hopkins MM. The treatment of cluster headache with repetitive intravenous dihydroergotamine. Headache 31,525–532 (1991).
  • Speight TM, Avery GS. Pizotifen (BC- 105); a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 3,159–203 (1972).
  • Ekbom K. Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta Neural Scand 45,601–610 (1969).
  • Couch JR Jr, Ziegler DK. Prednisone therapy for cluster headache. Headache 18, 219–221 (1978).
  • Anthony M, Daher BN. Mechanism of action of steroids in cluster headache. In: New Advances in Headache Research. Volume Two. Rose FC (Ed.). Smith Gordon, London, UK, 271–274 (1992).
  • Mirzai R, Chang C, Greenspan A, Gershwin ME. The pathogenesis of osteonecrosis and the relationships to corticosteroids. J. Asthma 36,77–95 (1999).
  • Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgla 9,195–198 (1989).
  • Freitag FG, Diamond S, Diamond ML, Urban G, Pepper B. Divalproex sodium in the preventative treatment of cluster headache. Headache 40,408 (2000).
  • Gallagher RM, Mueller LL, Freitag FG. Divalproex sodium in the treatment of migraine and cluster headaches. J. Am Osteopath. Assoc. 102,92–94 (2002).
  • El Amrani M, Massiou H, Bousser M. A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia 22,205–208 (2002).
  • Wheeler SD, Carrazana EJ. Topiramate- treated cluster headache. Neurology53, 234–236 (1999).
  • Forderreuther S, Mayer M, Straube A. Treatment of cluster headache with topiramate: effects and side effects in five patients. Cephalagla 22,186–189 (2002).
  • Lainez MJ, Pascual J, Pascual AM, Santonja JM, Ponz A, Salvador A. Topiramate in the prophylactic treatment of cluster headache. Headache 43,784–789 (2003).
  • Mathew NT Kailasam J, Meadors L. Prophylaxis of migraine, transformed migraine and cluster headache with topiramate. Headache 42,796–803 (2002).
  • Leone M, Dodick D, Rigamonti A eta]. Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia 23, 1001–1002 (2003).
  • Ahmed E Chronic cluster headache responding to gabapentin: a case report. Cephalalgia 20,252–253 (2000).
  • Tay BA, Ngan Kee WD, Chung DC. Gabapentin for the treatment and prophylaxis of cluster headache. Reg. Anesth. Pain Med. 26,373–375 (2001).
  • Leandri M, Luzzani M, Cruccu G, Gottlieb A. Drug-resistant cluster headache responding to gabapentin: a pilot study. Cephalalgia 21,744–746 (2001).
  • Brzezinski A. Melatonin in humans. N Engl. Med 336,186–195 (1997).
  • Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J. Neural. Neurosurg. PTch. 50,207–213 (1987).
  • Leone M, Lucini V, D'Amico D etal Twenty-four hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 15,224–229 (1995).
  • Leone M, D'Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 16,494–496 (1996).
  • Peres ME, Rozen TD. Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia 21,993–995 (2001).
  • Nicolodi M, Sicuteri F, Poggioni M. Hypothalamic modulation of nociception and reproduction in cluster headache. I. Therapeutic trials of leuprolide. Cephalalgia 13,253–257 (1993).
  • Sicuteri F, Fanciullacci M, Nicolodi M etal Substance P theory: a unique focus on the painful and painless phenomena of cluster headache. Headache 30,69–79 (1990).
  • Fusco BM, Marabini S, Maggi CA, Fiore G, Geppetti P. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain 59,321–325 (1994).
  • Fusco BM, Fiore G, Gallo F, Martelletti P, Giacovazzo M. `Capsaicin-sensitive' sensory neurons in cluster headache: pathophysiological aspects and therapeutic indication. Headache 34,132–137 (1994).
  • Marks DR, Rapoport A, Padla D etal A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache. Cephalalgla 13,114–116 (1993).
  • Saper JR, Klapper J, Mathew NT, Rapoport A, Phillips SB, Bernstein JE. Intranasal civamide for the treatment of episodic cluster headaches. Arch. Neural. 59, 990–994 (2002).
  • Peres ME, Stiles MA, Siow HC, Rozen TD, Young WB, Silberstein SD. Greater occipital nerve blockade for cluster headache. Cephalalgia 22,520–522 (2002).
  • Mulder LJ, Spierings EL. Naratriptan in the preventive treatment of cluster headache. Cephalalgla 22,815–817 (2002).
  • Wober C, Vigl K, Wessely P Eletriptan for short-term prophylaxis of cluster headache. Cephalagia 22,584 (2002).
  • Hering-Hanit R, Gadoth N. The use of baclofen in cluster headache. CI.117: Pain Headache Rep. 5,79-82 (2001).
  • Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW Treatment of headache with botulinum toxin A — a review according to evidence-based medicine criteria. Cephalalgla 22,699–710 (2002).
  • Caviness VS Jr, O'Brien P. Cluster headache: response to chlorpromazine. Headache20, 128–131 (1980).
  • Diamond S, Freitag FG, Prager J. Treatment of intractable cluster headache. Headache 26,42–46 (1986).
  • D'Andrea G, Perini F, Granella F, Cananzi A, Sergi A. Efficacy of transdermal clonidine in short-term treatment of cluster headache: a pilot study. Cephalalgia 15, 430–433 (1995).
  • Kirkpatrick PJ, O'Brien MD, MacCabe JJ. Trigeminal nerve section for chronic migrainous neuralgia. BE j Neurosurg. 7, 483–490 (1993).
  • Mathew NT, Hurt W Percutaneous radiofrequency trigeminal gangliorhizolysis in intractable cluster headache. Headache 28,328–331 (1988).
  • Lovely TJ, Kotsiakis X, Jannetta PJ. The surgical management of chronic cluster headache. Headache 38,590–594 (1998).
  • Franzini A, Ferroli P, Leone M, Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery52, 1099–1101 (2003).
  • Leone M, Franzini A, D'Amico D etal A three year experience with hypothalamic deep brain stimulation to relieve intractable chronic cluster headache. Cephalagla 23,579 (2003).
  • Dodick D, Trentman T, Zimmerman R, Eric E. Occipital nerve stimulation for intractable chronic primary headache disorders. Cephalagla 23,701 (2003).
  • Weiner R. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation 2,217–221 (1999).
  • Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 127, 220–230 (2004).
  • Tfelt-Hansen P. Prophylactic pharmacotherapy of cluster headache. In: Cluster Headache & Related Conclitions Olesen J, Goadsby PJ (Eds). Oxford University Press, Oxford, UK, 257–263 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.